Low-Dose Metformin Suppresses New Lesions After Polypectomy
In patients who have undergone a polypectomy, the antidiabetic drug metformin provides protection against the development of new adenomas and polyps, according to a double-blind, placebo-controlled, Phase III trial. The study, which was conducted in patients without diabetes, associated one year of metformin with a risk reduction relative to placebo of greater than 30%....

http://www.gastroendonews.com/In-the-News/Article/12-16/LowDose-Metformin-Suppresses-New-Lesions-After-Polypectomy/38776
Like
Comment
Share